Pediatrix Medical Group Inc reports results for the quarter ended September 30 - Earnings Summary

• Pediatrix Medical Group Inc MD.N reported quarterly adjusted earnings of 72 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 67 cents. The mean expectation of seven analysts for the quarter was for earnings of 65 cents per share. Wall Street expected results to range from 63 cents to 67 cents per share.

• Revenue rose 1.7% to $501.37 million from a year ago; analysts expected $498.14 million.

• Pediatrix Medical Group Inc's reported EPS for the quarter was 59 cents​.

• The company reported quarterly net income of $46.99 million.

• Pediatrix Medical Group Inc shares had risen by 12.4% this quarter and gained 35.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $28.00, about 3.3% below its last closing price of $28.91

This summary was machine generated from LSEG data October 29 at 02:18 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)